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Abstract
Purpose Understanding breast cancer mortality disparities by race and age is complex due to disease heterogeneity, comorbid 
disease, and the range of factors influencing access to care. It is important to understand how these factors group together 
within patients.
Methods We compared socioeconomic status (SES) and comorbidity factors in the Carolina Breast Cancer Study Phase 3 
(CBCS3, 2008–2013) to those for North Carolina using the 2010 Behavioral Risk Factor Surveillance Study. In addition, 
we used latent class analysis of CBCS3 data to identify covariate patterns by SES/comorbidities, barriers to care, and tumor 
characteristics and examined their associations with race and age using multinomial logistic regression.
Results Major SES and comorbidity patterns in CBCS3 participants were generally similar to patterns in the state. Latent 
classes were identified for SES/comorbidities, barriers to care, and tumor characteristics that varied by race and age. Com-
pared to white women, black women had lower SES (odds ratio (OR)  6.3, 95% confidence interval (CI) 5.2, 7.8), more 
barriers to care (OR 5.6, 95% CI 3.9, 8.1) and several aggregated tumor aggressiveness features. Compared to older women, 
younger women had higher SES (OR 0.5, 95% CI 0.4, 0.6), more barriers to care (OR 2.1, 95% CI 1.6, 2.9) and aggregated 
tumor aggressiveness features.
Conclusions CBCS3 is representative of North Carolina on comparable factors. Patterns of access to care and tumor char-
acteristics are intertwined with race and age, suggesting that interventions to address disparities will need to target both 
access and biology.
Introduction
US population-based breast cancer mortality rates are 42% 
higher for black women compared to white women and 
the mortality disparity is present at all ages and diagnostic 
stages [1, 2]. Since the early 1980s, this mortality gap has 
increased, partly reflecting disproportionate increases in 
survival among white women [1]. When considering age, 
black women age 45–54 have an absolute breast cancer mor-
tality difference twice as high as white women the same 
age [3]. Understanding breast cancer disparities by race and 
age is complex, due to the biological heterogeneity of the 
disease, presence of comorbid conditions, and the multifac-
eted interaction of social, behavioral, and access to care and 
care quality factors [4, 5]. Disentangling the biological and 
access factors that drive breast cancer mortality is critical to 
developing effective interventions.
To address the knowledge gap of how race, age, social 
determinants, comorbid conditions and tumor characteris-
tics interact, we used data from 2,998 women with inva-
sive breast cancer in the population-based Carolina Breast 
Cancer Study Phase 3 (CBCS3) (2008–2013), which over-
sampled younger (< 50 age at diagnosis) women and black 
women. We used latent class analysis (LCA), a person-
oriented approach to reduce highly dimensional data and 
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capture complex patterns that vary between people [6–9]. To 
demonstrate the generalizability of CBCS3 and better under-
stand how well this cohort represented the source popula-
tion, we also compared SES and access characteristics to the 
underlying population of North Carolina, using Behavioral 
Risk Factor Surveillance Study (BRFSS) data. North Caro-
lina is a socio-geographically and ethnically diverse state 
with wide ranging rural areas as well as focal urban areas 
and corresponding differences in access to care, income and 
education. The resulting data identify key person-centered 
groupings of patients and important multivariable contribu-
tors to breast cancer mortality.
Methods
Data sources and study populations
CBCS3 is a population-based case-only study that was initi-
ated to comprehensively evaluate the survivorship following 
invasive breast cancer diagnosis. All cases were identified 
within two months of diagnosis by rapid case ascertainment 
via the UNC Rapid Case Ascertainment Core in conjunc-
tion with North Carolina Central Cancer Registry. Younger 
(< 50 years in age) and black cases were oversampled by 
randomized recruitment so that half of the population was 
younger and half was black. All procedures performed in 
CBCS3 were in accordance with the ethical standards of the 
Institutional Review Board of the University of North Caro-
lina at Chapel Hill. Informed consent was obtained from 
all participants. Eligibility criteria defined participants as 
female, between the ages of 20 and 74 at the time of diagno-
sis, and receiving a first, primary diagnosis of breast cancer 
between May 1, 2008 and October 21, 2013 with residence 
in the 44-county study area.
For comparisons of CBCS3 to the general North Carolina 
population, we examined the 2010 Behavioral Risk Factor 
Surveillance System (BRFSS), a state-based random tel-
ephone survey with a cross-sectional study design. To be 
eligible for inclusion, participants were age 18 and older, 
resided in households within any North Carolina county. 
BRFSS interviews are conducted monthly and data are col-
lected and analyzed annually, and we utilized 2010 data, a 
midpoint time relative to CBCS3 study period. BRFSS data 
are weighted for the probability of telephone number selec-
tion, the number of adults in a household, and the number of 
phones in a household and are adjusted to reflect the demo-
graphic distribution of North Carolina’s adult (age 18 and 
older) population. To be comparable to the CBCS3 study 
population, we restricted the BRFSS population to women 
who self-identified as either black or non-Hispanic white and 
were between the ages of 20 and 74 years in age. The lead 
author (MAE) created and signed a Data Use Agreement for 
NC BRFSS for the analysis of publicly available NC BRFSS 
data. Sampling weights were applied to both data sources 
to match distributions in the original source population; in 
CBCS3 the source population was the 44-county study area 
and for NC BRFSS it was the entire state of North Carolina. 
All presented SES and comorbid factors were assessed in 
both CBCS3 and NC BRFSS. The categorization of these 
variables differed between datasets, however, we harmo-
nized the CBCS3 and BRFSS for each categorical variable.
SES and Comorbidities Factors: CBCS3 and NC BRFSS
For CBCS3, SES and comorbidity information were 
assessed by a baseline questionnaire and nurse-administered 
questionnaire on family history and body mass index (BMI) 
measurement within, on average, 5 months of diagnosis. 
For 2010 NC BRFSS, SES and comorbid information were 
assessed via a landline telephone survey. SES variables of 
interest included self-reported race (white vs. black), age 
(age at diagnosis in CBCS3; age at interview in BRFSS) 
(< 50 years of age vs. ≥ 50 years of age), marital status (mar-
ried vs. not married), income (USD > $50K, $15K to $50K 
and < $15K), education (college degree or higher, some 
college, technical or business school, high school graduate/
GED and 0–12 years, no but high school degree), current 
health insurance (yes vs. no) and rural address (yes vs. no).
Education, income and marital status had comparable cat-
egories between CBCS3 and BRFSS and were harmonized 
by categorization. For health insurance, CBCS3 participants 
were asked at baseline if they currently had health insurance 
coverage and the type of insurance (private health insurance 
purchased on their own or by husband or partner, private 
health insurance from their employer or workplace or that of 
their husband or partner, Medicaid, Medicare or other insur-
ance that covered part of their medical bills). In BRFSS, 
participants were asked, “Do you have any kind of health 
care coverage, including health insurance, prepaid plans 
as HMOs, or government plans such a Medicare”. A “yes” 
response was coded as current health care coverage. The var-
iable on current health insurance was dichotomous: “yes vs. 
no”. For rurality, CBCS3 participants were asked about their 
community type since age 25. We then collapsed the cat-
egorization to include city (large city [population > 100K], 
suburb, and town or city with a population of < 10K, 10–50K 
and 50–100K) vs. rural (rural, non-farm, in the country and 
on a farm). In BRFSS, rural status was assessed based on 
metropolitan statistical areas (MSA), which are defined by 
the US Office of Management and Budget as a metropolitan 
area distinct form another metropolitan area. MSA codes 
included: in the center city of an MSA, outside the center 
city of an MSA but inside the county containing the center 
city, inside a suburban county of the MSA and not in an 
MSA. Rural status included the category of “not in an MSA” 
while all other category we coded as “non-rural”. The final 
rural variable was coded as “yes vs. no”.
Comorbidity factors included diabetes (yes vs. no), heart 
disease (yes vs. no), smoking status (not current vs. cur-
rent), and body mass index (BMI < 25 kg/m2, 25–30 kg/m2 
and 30 kg/m2). In CBCS3, diabetes and heart disease were 
determined by medical record abstraction as a comorbid-
ity to breast cancer and were dichotomized as “yes vs. no”. 
In BRFSS, participants were asked, “have you ever been 
told by a doctor that you have diabetes?” If “Yes” and the 
respondent was female, the participant was asked, “Was this 
only when you were pregnant?” An affirmative response was 
coded as pre-diabetes or borderline if answered yes, which 
was less that 1% frequency. Participants were also asked if 
they had ever been told they had angina or coronary heart 
disease, an affirmative response was coded as “yes”. For 
smoking, CBCS3 participants were asked about their current 
tobacco smoking status via questionnaire. Current smokers 
included participants who had: (1) smoked at least 100 ciga-
rettes in their lifetime and reported smoking at the time of 
the interview, or (2) quit at diagnosis and within 1 year prior 
to diagnosis. Non-current smokers included former smokers 
(smoked at least 100 cigarettes in lifetime and who quit at 
least 1 year prior to diagnosis) and never smokers; 62.7% of 
non-smokers were never smokers. In BRFSS, a computed 
smoking status was used to assess current smoking status, 
originally with 4 levels: everyday smoker, someday smoker, 
former and non-smoker, recoded to “current (everyday and 
someday) vs. not current (former and non-smoker)”. For 
anthropometry, CBCS3 BMI was based on nurse measured 
anthropometric data and was measured in weight in kilo-
grams/height in meters squared. In BRFSS, BMI was cal-
culated and categorized as: neither overweight nor obese, 
overweight and obese. The variable was derived from self-
report height and weight. The final variable for BMI was: 
less than or equal to 25, 25 to 30, and greater than 30.
Access to medical care factors: CBCS3
Access to medical care factors included currently insured 
(yes vs. no), insurance type, rural residence (yes vs. no), 
financial issues (yes vs. no), transportation issues (yes vs. 
no), and job loss (yes vs. no). Participants were asked about 
insurance, insurance type, rural status, and job loss at base-
line. Private insurance was defined as private health insur-
ance from employer or workplace or that of the participant’s 
husband or partner. Other types included Medicaid, Medi-
care, other and none. For job loss, participants were asked if 
they had lost their job to diagnosis of breast cancer. Partici-
pants were also asked at approximately 18 months follow-up 
telephone survey from baseline if they could not see a doctor 
because of financial and transportation issues.
Tumor characteristics: CBCS3
Tumor size (≤ 2 cm vs. > 2 cm), nodal status (positive vs. 
negative) and histologic grade (I and II vs. III) were obtained 
from medical records abstraction. Estrogen receptor (ER) 
status, progesterone receptor (PR) status, human epidermal 
growth factor receptor 2 (HER2), and Triple-Negative (TN) 
status (positive vs. negative) were obtained from pathol-
ogy reports abstraction for 98% of cases in CBCS3. IHC 
staining was done for the remaining 2% of cases without 
medical record data [10]. HER2 was derived from Immuno-
histochemical (IHC) and/or Fluorescence In Situ Hybridiza-
tion (FISH) assay. A positive ER or PR was defined as > 10% 
cut point. Borderlines, which represented 8% of cases, were 
included with negative status consistent with the recommen-
dation of Allott et al., which showed that ER borderlines 
were more likely to have non-luminal subtype [11].
Statistical analysis
Weighted percentages were calculated for selected par-
ticipants’ SES and comorbidity factors by race and age in 
CBCS3 and NC BRFSS. We examined SES, comorbidities, 
access to medical care and the individual tumor charac-
teristic factors using latent class analysis (LCA) to iden-
tity groups of individuals based on numerical factors using 
PROC LCA a SAS package [12]. LCA identifies unobserv-
able, or latent, subgroups within a population that are mutu-
ally exclusive and exhaustive [13]. The model probabilisti-
cally groups each observation into a latent class, a variable 
indicating underlying subgroups of individuals based on 
observed characteristics. An iterative approach to param-
eter estimation using expectation–maximization (EM) for 
maximum-likelihood (ML) estimation generated estimates 
of all model parameters and item-response probabilities of 
class assignment. We used several criteria to determine the 
number of classes from the ML solution using 100,000 sets 
of starting values. We examined the G2 likelihood-ratio test 
statistic, Akaike’s information criterion (AIC) and Bayesian 
Information Criterion (BIC), a goodness-of-fit measure to 
find more parsimonious models, where a smaller AIC and 
BIC suggest a better model fit. Additionally, we evaluated 
entropy, where higher values reflect better classification. 
We then expanded model specification for multiple-groups 
LCA to examine differences in risk factor patterns by race 
and age. Here, we tested for measurement invariance across 
groups for differences between younger and older and black 
and white women. We compared a series of latent class mod-
els to determine the optimal model for parsimony and model 
fit using the criteria described above.
We examined the distribution of latent class categories 
stratified by race and age. We used logistic regressions 
and polytomous logistic regressions to estimate odd ratios 
(ORs) and 95% confidence intervals (CIs) as the measure of 
association between SES/comorbidities, access to care pat-
terns, individual tumor factors latent classes and race/age. 
All statistical analyses were conducted with SAS statistical 
package version 9.3 (SAS Institute, Inc., Cary, NC). P values 
were for a two-sided test with an alpha of 0.05 for statistical 
significance.
Results
CBCS3 in context of the state of North Carolina
The CBCS3 was designed to assess race and age differences 
in breast cancer outcomes, and therefore, oversampled black 
and younger women. However, our findings show that after 
weighting for randomized recruitment, CBCS3 shows gener-
ally similar distributions of socioeconomic and comorbidity 
variables as the BRFSS data for the state as a whole (Fig. 1). 
Racial and age-specific patterns for marital status, diabetes, 
heart disease, smoking status and income were very similar 
in both datasets. Compared to white women, black women 
were less likely to be married, more commonly resided in 
non-rural areas, were more likely to be obese, had lower 
income and had lower proportions of health insurance and 
education. Compared to older women, younger women were 
more likely to earn higher levels of income and have higher 
level of education. Some expected differences were observed 
for rurality, given that the CBCS3 sampled only from the 
most populous 44-counties in the state. The CBCS3 popu-
lation also had a slightly greater proportion of women with 
current health insurance and post high school education. 
White women in CBCS3 were somewhat more likely to be 
in the highest category of income compared to white women 
in BRFSS. In both populations, each of the 9 categorical 
variables for SES and comorbidity had at least 10% preva-
lence, except heart disease shown in Supplement Tables 1A 
and 1B.
Compared to white women in CBCS3, black women in 
CBCS had lower proportions of private health insurance and 
rural residence, but higher proportions of Medicare and both 
financial and transportation barriers to care (Supplemental 
Table 2). Compared to older white women, younger white 
women and both younger and older black women in CBCS 
had higher proportions of Medicaid, job loss due to breast 
cancer diagnosis, and financial and transportation barriers 
to care.
Barriers to cancer care and clinical characteristics of 
tumors are not included in BRFSS, but we assessed distri-
butions of these variables in CBCS3. Supplemental Table 2 
shows individual barriers to care by race and age and Sup-
plemental Table  3 shows clinical characteristics. Black 
younger women had more financial and transportation 
issues 
and experienced more job loss due to breast cancer diag-
nosis. Overall, older white women had the most favorable 
tumor characteristics, with more aggressive features seen 
for both younger and black women (Supplemental Fig. 1).
Latent classes and patterns by race and age
Given the multiplicity of variables that comprise socioeco-
nomic status, barriers to care, and tumor biology, respec-
tively, and the tendency for characteristics to aggregate 
within individuals, we sought to develop latent classes based 
on these variables. We a priori identified three separate 
latent class domains: (1) SES/comorbidity factors, (2) bar-
rier to care factors and (3) tumor characteristics. We chose 
these domains because functionally they relate separately to 
the lived experience and exposure, access factors, which we 
considered to be most intervenable, and clinical intervention 
factors. For the SES/comorbidity factors, a model with two 
latent classes had lowest AIC, BIC and likelihood-ratio G2 
statistic compared to one, three, four, five or six-class mod-
els. For the barriers to care, two classes were optimal, and 
for tumor characteristics, four latent classes had the lowest 
AIC, BIC and likelihood-ratio G2 statistic. We examined 
contingency tables (Supplemental Tables 4–6) of the latent 
class posterior probabilities. We observed no correlation 
among the latent class groups and no further collapsibility, 
suggesting that these three latent classes were a stable clas-
sification solution.
Social, comorbidity, access to care and tumor factors 
determined distinct class membership. Figure 2 shows the 
relative frequency of each latent class and the posterior prob-
abilities that members of each latent class endorsed each 
factor category in the models for: SES and comorbidity fac-
tors (panel A), barriers to care (panel B) and tumor charac-
teristics (panel C). For the two-class model measuring SES 
and comorbidity factors, 54% were in the High SES/Low 
Comorbidity latent class, which was characterized by a high 
probability of the highest categories of income, education 
and being married and low probability of comorbidities. For 
the two-class model for barriers to care, 87% of women were 
in the Less Barriers latent class, with lower probability of 
being uninsured, having financial or transportation issues, 
residing in rural areas, or job loss. For the four-class model 
measuring tumor characteristics, 40% of the women were 
in the HR+/HER2−/Node Negative latent class, which was 
characterized as HR+, HER2−, smaller tumor size, node 
negative and lower grade tumors. The HER2+/Higher Grade 
class (10%) was characterized by highest probabilities of 
having HER2+ breast cancers and higher probabilities of 
higher grade, node positive and larger tumor size. The HR+/
HER2−/Larger Tumor/Node Positive class (29%) was char-
acterized by highest probabilities of having HR+, larger 
tumor size and node positive tumors. Lastly, the TNBC/
Higher Grade class (21%) was characterized by highest 
probabilities of TNBC and higher grade tumors.
Race and age were associated with latent class mem-
bership for all three domains we evaluated. As shown 
in Fig. 3, when controlling for the effect of age, black 
race was positively associated with low SES (OR 6.3, 
95% CI 5.2, 7.8; vs. high SES), more barriers to medical 
care (OR 5.6, 95% CI 3.9, 8.1; vs. less barriers) and more 
aggressive aggregated tumor characteristics (e.g., TNBC 
OR 3.8, 95% CI 3.0, 4.8) compared to white women. Con-









































































































































































Fig. 1  Distributions of categorical demographic and comorbid characteristics for women in the Carolina Breast Cancer Study 3 (2008–2013) and 
Behavioral Risk Factor Surveillance System (2010), by age and race
with low SES (OR 0.5, 95% CI 0.41, 0.61; vs. high SES), 
but positively associated with more barriers to medical 
care (OR 2.1, 95% CI 1.6, 2.9; vs. less barriers) and more 
aggressive aggregated tumor characteristics (e.g., TNBC 
OR 2.3, 95% CI 1.8, 2.9). Further cross-classification on 
race and age also showed strong determinants of class 
membership patterns (Table 1). Taken together, these mod-
els suggest a compounding of high risk SES, access, and 
tumor biological factors for younger and black women. 
Discussion
The CBCS3 population-based cohort of women with breast 
cancer, which oversampled younger and black women, 
has helped further elucidate the complexity of race and 
age disparities. Women in CBCS3 were representative 
of women as a whole in North Carolina, with women in 
CBCS3 and BRFSS showing similar distributions of SES 
and comorbidity factors. Slightly higher income, education 
Fig. 2  Probabilities of responses 
to items for a two-class model 
measuring SES/comorbidities, 
b two-class model measuring 
access to medical care c four-
class model measuring tumor 
characteristics
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Fig. 3  Odds ratios and 95% confidence intervals for association of race and age with specific latent classes, Carolina Breast Cancer Study 3 
(2008–2013)
Table 1  Distribution and odds ratios with 95% confidence intervals of latent classes, Carolina Breast Cancer Study 3 (2008–2013) by age and 
race
Bold indicates the significance of 95% confidence intervals
Latent class domains not mutually adjusting for one another
SES Socioeconomic status, HER2+ human epidermal growth factor receptor 2 positive, TNBC triple-negative breast cancer
a N = 2,987
All cases 
(n = 2998)










No (%) No (%) No (%) No (%) No (%)
SES/Comorbidity latent classes
 Low SES/high comorbidity 1,428 (47.6) 134 (9.4) 259 (18.1) 455 (31.9) 580 (40.6)
 High SES/low comorbidity 1,570 (52.4) 617 (39.3) 493 (31.4) 286 (18.2) 174 (11.1)
 Low vs. high, OR (95% CI) 0.5 (0.4–0.6) 1.0 Ref 3.2 (2.5–4.1) 6.2 (4.7–8.1)
Access to care latent classes
 Less barriers to care 2,514 (84.1) 709 (28.2) 737 (29.3) 482 (19.2) 574 (22.8)
 More barriers to care 476 (15.9) 42 (8.8) 15 (3.2) 258 (54.2) 180 (37.8)
 Less vs. more, OR (95% CI) 3.3 (1.6–6.4) 1.0 Ref 15.3 (7.8–29.9) 7.8 (4.1–15.4)
Tumor characteristics latent  classesa
 HR+/HER2−/node negative 1,091 (36.5) 290 (26.6) 419 (38.4) 117 (10.7) 265 (24.3)
 HER2+/higher grade 335 (11.2) 86 (25.7) 59 (17.6) 99 (29.5) 91 (27.2)
 HR+/HER2−/larger tumor/node positive 944 (31.6) 259 (27.4) 181 (19.2) 301 (31.9) 203 (21.5)
 TNBC/higher grade 617 (20.7) 115 (18.6) 90 (14.6) 222 (36.0) 190 (30.8)
 HER2+vs. HR+/HER2−/Node−, OR (95% CI) 2.6 (1.9–3.6) 1.0 Ref 6.3 (4.3–9.1) 2.0 (1.4–2.8)
 HR+ vs. HR+/HER2−/Node−, OR (95% CI) 2.3 (1.5–3.6) 1.0 Ref 6.3 (3.9–10.0) 2.6 (2.5–3.8)
 TNBC vs. HR+/HER2−/Node−, OR (95% CI) 2.0 (1.5–2.9) 1.0 Ref 9.0 (6.1–13.0) 3.4 (2.5–4.6)
and non-rural residence in CBCS3 compared to BRFSS as 
a whole likely reflects CBCS3′s sampling of more popu-
lous counties. It may also reflect differences in participa-
tion demand for the two studies, with CBCS3 requiring a 
home visit, an extensive follow-up schedule and BRFSS 
including just a single telephone interview. Many indi-
vidual variables differed by race and age in the CBCS3 
and to evaluate person-centered patterns, we used latent 
class analysis to show that black women were much more 
likely to have low SES, more aggressive aggregated tumor 
characteristics, and experience more barriers to medical 
care. Compared to older women, younger women were 
more likely to have higher SES, but had more aggressive 
aggregated tumor characteristics and experienced more 
barriers to medical care. Constructing and examining 
these covariates in aggregate helps to summarize a deeper 
understanding and a more nuanced view of race and age 
in breast cancer disparities.
Based on the previous literature, racial differences 
observed in CBCS3 portend important differences in mor-
tality. Racial differences in diagnosis, treatment and mortal-
ity have been shown to be greater among women who are 
unmarried [14], live in more rural areas [15], have lower 
SES [16–19], and have more comorbid conditions [20]. 
Our observation of higher obesity rates in CBCS3 patients 
compared to the NC BRFSS population may be explained 
by obesity’s status as a risk factor for cancer [21–23]. An 
additional consideration is the difference in the measurement 
of height and weight in both studies. A nurse in CBCS3 
objectively measured height and weight, whereas in BRFSS, 
these measures were self-reported, which tends to result in 
underreporting of obesity [24, 25]. Social, economic and 
cultural barriers to care, including insurance and cancer-
care cost, have also been shown to contribute to racial dis-
parities [26–28]. Our results are consistent with the well-
established literature on racial differences in tumor biology. 
Black women are at much greater risk of higher grade, 
ER-negative and triple-negative breast cancers [29–31], 
even after controlling for age and stage. Younger and black 
women are more likely to have subtypes of breast cancer 
tumors that are more aggressive, treatment resistant and 
without clear molecular targets for treatment [32]. A pub-
lished review highlights how both tumor biology and quality 
of care potentially increase the racial mortality gap [33]. 
Yet, many manuscripts continue to consider tumor biology 
and access separately, with little integration. Much remains 
poorly understood about the cancer experience of younger 
black women and thus, the disparity is widening [4]. It is 
important to develop integrated approaches to studying 
breast cancer mortality.
Breast cancer mortality is higher in poorer communities 
regardless of race/ethnicity [34]. Previous analyses of racial 
identity and socioeconomic and social environment factors 
have made it evident that race is a sociopolitical construct 
in additional to a biological or genetic characteristic [35]. 
Socioeconomic disadvantages are more prevalent in Black 
communities compared to white communities, including 
insurance, income, education, economic, environmental 
and structural factors [36]. Prevalences for modifiable fac-
tors, such as cigarette smoking and obesity, are higher with 
less education and below poverty level among women [34], 
in part, because targeted cigarette company advertisements 
[37], environmental changes and decreases in physical activ-
ity [38].
Previous population-based breast cancer studies have 
used area-level SES composite scores (e.g., area-level edu-
cation or income and/or individual insurance) [28, 39, 40], 
but such approaches have varying validity by dataset because 
SES manifests in different ways in distinct populations [41]. 
Area-level SES has been used as a continuous index of 
social and economic indicators, but it is difficult to interpret 
because it lacks an identifiable unit and the assumption of 
a constant linear relationship may not be valid. Addition-
ally, SES measured at the area-level does not fully capture 
individual variation, which is needed to inform intervention 
approaches. Palumbo et al. using, latent class models, iden-
tified factors of advantage and disadvantage neighborhood 
SES and measured the association of neighborhood SES, 
race and breast cancer tumor characteristics. Consistent with 
our findings, they found that high disadvantage neighbor-
hood SES (i.e., higher proportions of neighborhoods with 
single with dependents, below poverty line, low vehicle 
access, black race) was associated with more aggressive 
tumor characteristics (i.e., lower proportions of Luminal A 
breast cancers, earlier stage, smaller size and lower grade) 
[42]. Importantly, this study also found lack of concordance 
when comparing the latent class variables with a continuous 
neighborhood SES index, suggesting that SES characteris-
tics are better represented by multiple latent classes than by 
a single index. Indicators of SES are not perfectly correlated, 
which makes LCA an advantageous alternative measurement 
tool in assessing multidimensional SES factors in cancer 
outcomes research. Strong links between SES, tumor char-
acteristics, and access patterns suggest that analyses that 
integrate biological and access characteristics are important 
for understanding mortality disparities. Many cancer biology 
studies lack data on SES and access variables, and few stud-
ies have adequately integrated cancer biology and barriers 
to care in understanding disparities. The current analysis 
extends previous studies that by incorporating reported bar-
riers to care, tumor characteristics patterns, individual level 
SES, and by examining these differences by race, with race 
as a covariate not as a characteristic of the latent class mod-
els, and by race and age simultaneously.
Our study should be interpreted with some limitations 
in mind. First, we were unable to restrict our BRFSS 
analysis to the same sampling region used for CBCS3 
because we did not have access to the BRFSS geocoded 
data so some comparisons may reflect regional differences 
in the state rather than differences between the study popu-
lation and the source population. Second, it is possible that 
we are underestimating some access and biological dispar-
ities relative to the most underserved patients in the state. 
Notably, over 90% of CBCS3 women have some health 
insurance, higher than reported rates nationally and in NC 
during this time period. However, we did include many 
uninsured patients and because our goal was to identify 
patterns in overall SES and comorbidity factors, and we 
do not expect that the latent classes would be substantially 
different when expanding to the entirety of NC. Third, the 
access to care measures, including financial issues, are 
self-reported. As such, they may represent heterogeneous 
types of financial issues and varying sensitivity to finan-
cial stressors. Fourth, we also considered only a limited 
number of potential domains that could be associated with 
mortality disparities, however, we were able to decrease 
dimensionality of these domains considerably. Our study 
has several key strengths including the population-based 
study design of CBCS3, which oversampled young and 
black women with breast cancer. Another strength is the 
depth of data on socioeconomic, demographic, access and 
tumor biology. Finally, our population size was substantial 
enough to be able to find stable latent classes.
Conclusion
Overall, previous studies have shown that breast cancer 
mortality is a complex combination of race, SES, and 
genetic factors. This paper is a step towards more fully 
capturing and comprehensively examining the interaction 
and patterning of all these important indicators that reflect 
health disparity.
Probabilistic model-based clustering methods identi-
fied unique patterns based on SES, barriers to care, and 
biological factors. Together, these factors can help specify 
interventions to reduce breast cancer mortality disparities. 
Future research should evaluate how these factors relate to 
outcomes, such as treatment delays and recurrence.
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